Paraghurt for Patients with Irritable Bowel Syndrome:A Controlled Clinical Investigation from General Practice

Abstract

A comparison of Paraghurt tablets (freeze-dried culture of Streptococcus faecium) and placebo was carried out in patients with irritable bowel syndrome in a double-blind trial in Danish general practices. Fifty-four patients (42 females and 12 males) with an average duration of the disease of seven years were treated for four weeks. The clinical symptoms were registered prior to the treatment and after two and four weeks. The clinical effect was assessed according to changes in number of abdominal symptoms, the patients' registrations on rating scales, and the physicians' overall estimations. According to all three parameters a markedly better effect of Paraghurt was seen. Thus, after four weeks 81% of the Paraghurt- and 41% of the placebo-treated patients had improved according to the physicians' overall assessment (p = 0.002). The result of the trial suggests that Paraghurt is a valuable alternative in the treatment of irritable bowel syndrome.

Probiotic Therapy of the Irritable Bowel Syndrome: Why Is the Evidence Still Poor and What Can Be Done About It?

“…35,36 Based on hand-searches of the published meta-analyses, we added 3 more studies, [37][38][39] resulting in a total of 55 articles.…”

“…37,52,56, Four studies employed a cross-over design, 52,56,90,105 which is frequently used for motivational purposes (patients are easier to recruit when they are offered an effective treatment, at least for a part of the trial). However, they are difficult to evaluate since the assumption that the data in both periods is equal and can be merged may be distorted by unblinding and conditioning effects.…”

Irritable bowel syndrome: the problem and the problem of treating it – is there a role for probiotics?

“…Similarly, because probiotics potentially modulate a number of the pathophysiological mechanisms involved in IBS, they are usually given to all subtypes of the condition both in the clinical setting as well as in therapeutic trials. There have been twenty-eight controlled trials assessing the efficacy of probiotics in adults suffering from IBS with twenty (71 %) showing a positive effect (43,(57)(58)(59)(60)(61)(62)(63)(64)(65)(66)(67)(68)(69)(70)(71)(72)(73)(74)(75) , seven showing no effect (43,(76)(77)(78)(79)(80)(81) and one leading to a deterioration of symptoms (82) . In addition, four trials in children all gave positive results (83)(84)(85)(86) .…”

Irritable Bowel Syndrome and Its Relationship With Intestinal Microflora

“…Действительно, введение пробиотика влияло значительно эффективнее, чем плацебо, на улучшение общих симпто-мов [69][70][71][72][73][74][75][76][77][78].…”